Idogen - Times Square - Idogen
Idogen Annual report 2018 - Idogen
Idogen's first trading day on Nasdaq First North noted at Times Square in New York - Idogen
Approved study and prestigious meetings in fibrosis put Cereno Scientific in the limelight - BioStock
Idogen
Idogen
Idogen
Sharon Longhurst - Idogen
Portfolio Companies - Ventac Partners
Idogen
Idogen - Crunchbase Company Profile & Funding
ABOUT US | abbreos
Logga till PM - Idogen
Xintela - Advancing integrins as innovation engine | Edison
Idogen
Idogen AB Interim report January–September 2019 - Idogen
Idogen presents at Stora Aktiedagen in Gothenburg November 4th - Idogen
Idogen AB Information | Idogen AB Profile
Portfolio Companies - Ventac Partners
Idogen's cell technology successfully advanced to large-scale production - Idogen
Portfolio Companies - Ventac Partners
PDF) Comparative secretome of ovarian serous carcinoma: Gelsolin in the spotlight
Idogen presentation - Idogen
Portfolio Companies - Ventac Partners
Amy Cunningham-Mays (@MaysEamays926) / Twitter
